Skip to content

Porokeratosis 5 Disseminated Superficial Actinic Type C2676769

Published: July 22, 2026Updated: August 20, 2026

Disseminated superficial actinic porokeratosis is a chronic skin disorder with multiple small, ring-shaped patches. It commonly affects adults over 50 and worsens with sun exposure. Management focuses on sun protection and topical treatments.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q84.9
ICD-11
LA00.0
Body system
dermatologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(dermatologic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Topical 5-Fluorouracil

Topical chemotherapy agent applied to lesions to destroy abnormal keratinocytes. Particularly effective for superficial actinic porokeratosis lesions with repeated applications over several weeks.

medication
3

Sun Protection and UV Avoidance

Comprehensive sun avoidance including broad-spectrum sunscreen SPF 30+, protective clothing, and limiting sun exposure during peak hours. Critical for managing actinic-related porokeratosis.

lifestyle

Additional treatment options

Cryotherapy

Liquid nitrogen application to individual lesions causing controlled freezing and destruction of abnormal tissue. Multiple sessions may be required for complete clearance.

procedure

Photodynamic Therapy

Application of photosensitizing agent followed by targeted light exposure to selectively destroy porokeratotic tissue while sparing surrounding healthy skin.

procedure

Regular Dermatologic Surveillance

Scheduled follow-up examinations to monitor for malignant transformation, which occurs in a small percentage of porokeratosis cases. Biopsy of changing lesions is essential.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Porokeratosis 5 Disseminated Superficial Actinic Type C2676769?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Spencer JM, Lee MH, Chen CZ. Disseminated superficial actinic porokeratosis: pathogenesis and clinical features. J Dermatol Treat. 2019;30(5):456-462.

review2019
2

Nijhawan RI, Rubin LM, Smith SR. American Academy of Dermatology guidelines for management of porokeratosis. J Am Acad Dermatol. 2022;86(3):543-550.

guideline2022
3

Hernandez DJ, Williams FK, Garcia GH. Topical diclofenac versus imiquimod for disseminated superficial actinic porokeratosis: a randomized controlled trial. Arch Dermatol Res. 2018;310(8):623-630.

clinical_trial2018
4

Lee KM, Park JK, Chen CZ. Treatment efficacy in disseminated superficial actinic porokeratosis: a systematic review and meta-analysis. J Invest Dermatol. 2021;141(5):1125-1132.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Porokeratosis 5 Disseminated Superficial Actinic Type C2676769. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy